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Background Communication of Mild Cognitive Impairment (MCI) diagnoses is 
challenging due to its heterogeneity and unclear prognosis. 
 
Aim To identify how MCI is communicated and to explore the relationship with 
patient and companion understanding. 
 
Method Conversation analysis identified whether MCI was named and explained in 
43 video recorded diagnosis feedback meetings. Afterwards, patients and 
companions were asked to name the diagnosis to assess understanding.  
 
Results MCI was not named in 21% meetings. Symptoms were explained as (1) a 
result of vascular conditions (49%), (2) a stage between normal ageing and dementia 
(30%), or (3) caused by psychological factors (21%). 54% of prognosis discussions 
included mention of dementia. There was no association between symptom 
explanations and whether prognosis discussions included dementia. 57% patients 
and 37% companions reported not having or not knowing their diagnosis after the 
meeting. They were more likely to report MCI when prognosis discussions included 
dementia. 
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Conclusions Doctors offer three different explanations of MCI to patients. The 
increased risk of dementia was not discussed in half the diagnostic feedback 
meetings. This is likely to reflect the heterogeneity in the definition, cause and likely 
prognosis of MCI presentations. Clearer and more consistent communication, 
particularly about the increased risk of dementia, may increase patient 
understanding and enable lifestyle changes to prevent some people progressing to 
dementia. 
 
Key words: Mild Cognitive Impairment, Vascular Cognitive Impairment, 
Communication, Diagnosis, Prognosis, Understanding 
 
Key points: 
• Mild Cognitive Impairment (MCI) is a heterogenous and debated clinical 
construct, which is reflected in wide variation in how it is communicated 
to patients.  
• There are three different explanations of MCI communicated to 
patients: (1) impairments due to vascular damage, (2) impairments as a 
stage between ageing and dementia, and (3) impairments caused by 
psychological factors.  
• 54% of diagnosis discussions included dementia as a possibility for the 
future. 
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• Patients and companions were more likely to report MCI as the 









Sharing a diagnosis of Mild Cognitive Impairment (MCI) could enable people to 
manage their symptoms and make lifestyle changes that may prevent dementia1. 
Modifiable risk factors for progression include diabetes, neuropsychiatric symptoms 
and low folate, indicating that dietary or psychological interventions may have an 
impact2. There is an estimated 15-20% prevalence of MCI in the over 60s and a rate 
of progression to dementia from 8-15% per year3.  
 
However, MCI has a reputation as an unstable or heterogenous diagnosis, which is 
attributed to uncertainty about its causes and subtypes4,5. MCI has evolved from 
describing an ambiguous state between normal ageing and dementia to 
representing an effort to discriminate between different disease processes with 
different prognoses and treatments3,6. Research has identified varying features such 
as amnestic vs non-amnestic symptoms, single vs multiple cognitive domains, 
vascular vs non-vascular causes, prognostic indicators, and biomarkers3,7-9. 
Additionally, MCI prognoses have been demonstrated to vary: from progression to 
dementia to reversal of symptoms2,10. 
 
This heterogeneity has an impact on communication of MCI diagnoses to 
patients11,12. Clinicians report discussing prognosis at MCI diagnosis 60-80% of the 
time13,14. Patients experience MCI with a mixture of relief in not having dementia 
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and frustration about the ambiguity surrounding the diagnosis15,16, with patient 
explanations of MCI ranging from ‘not dementia’ to mild Alzheimer’s disease17. This 
confusion may be caused by differences in diagnostic communication. 
 
Given the heterogeneity of MCI, clinicians may be altering their diagnostic 
communication according to their judgement of cause of the patient’s symptoms 
and the likelihood of progression to dementia. This could affect the information 
patients take on board. The aim of this study was to (1) identify how doctors 
communicate a diagnosis of MCI and its prognosis, and (2) explore the relationship 




This research is part of an NIHR RfPB funded study exploring communication in 
memory clinics (ShareD, ‘Shared decision making in mild to moderate dementia’ PB-
PG-1111-26063), with results published elsewhere11,18,19. Camden and Islington 
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The data consists of video recordings of diagnosis feedback meetings that took place 
across 9 UK-based secondary care memory clinics across rural and urban settings. 
Diagnostic feedback meetings were video recorded and transcribed. The clinic 
structures and recruitment methods have been described in previous ShareD 
publications11,18,19.  
 
Patient and companion understanding 
 
Patients and companions were asked “Did the doctor give a name (or diagnosis) for 
your memory problem? If so, what?” The responses to this question were used to 
assess understanding of the diagnosis.  
 
After each meeting, the doctor completed a form indicating the person’s diagnosis. 
The cases where the doctor indicated a diagnosis of ‘Mild Cognitive Impairment’ 




We used conversation analysis (CA), an in-depth, qualitative method to micro-
analyse communication20. Excerpts where diagnosis was discussed were identified 
from watching the recordings and transcribed using CA methods21. This enabled 
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description of communication practices doctors use to deliver MCI diagnosis. These 
practices were then coded to allow quantitative descriptions. Fisher’s Exact test 
explored relationships between practices and patient and companion understanding.  
 
Validity was addressed through repeated analysis within and external to the 
research team22. The inclusion of data from different doctors in a variety of clinics, as 





Participant information can be found in Table 1. The consent rate for clinicians 
participating in ShareD was 88%. This dataset includes 12 doctors from 6 memory 
clinics. There was a median of 2 patients per doctor, ranging from 1 to 15.  
[INSERT TABLE 1 HERE] 
Of 215 patient participants recruited to ShareD (consent rate 51%), 47 received 
diagnoses of MCI or VCI. The remaining patients received diagnoses of dementia 
(n=101), mood related diagnoses such as depression or anxiety (n=21), were referred 
for further testing (n=34) or did not receive a diagnosis (n=22), with doctors advising 
re-referral for tests at a later date if symptoms worsened. Forty-three videos are 
included in this data set, the remaining 4 had technical difficulties with their 
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recordings and could not be included. The mean Addenbrooke’s Cognitive 
Examination III (ACE-III)24 test score for participants with MCI or VCI diagnoses was 
83 (range=60-94, SD=8.5). 
 
In 5 meetings patients attended without a companion. Twenty-six patients attended 
with a spouse/partner, 6 with a child/child-in-law, 3 with a friend, 1 with a sibling 
and 2 identified as ‘other’. 
 
Communication of MCI diagnosis 
 
Communication of diagnosis varied. Figure 1 shows a flow of the diagnostic 
information given to patients. 
[INSERT FIGURE 1 HERE] 
 
Selected extracts are presented below. CA transcription symbols have been 
removed; detailed transcripts and further examples are available from the authors. 
The numbers in brackets represent timed pauses in seconds and squared brackets 
represent overlapping speech. 
 
Diagnosis communicated to patients and explanations for symptoms 
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In all but one case, the diagnosis was presented explicitly as ‘not dementia’.  
 
Extract 1 
DR:  but as I said it’s not severe enough to be dementia.  
     It’s- it’s not that (0.3) but we call it mild cognitive  
     impairment. 
 
MCI or VCI was explicitly named in 34/43 meetings (79%, MCI=29, VCI=5), as in 
Extract 1. In 13/29 meetings where MCI was named, doctors explained MCI as a 
stage between ‘normal’ ageing and dementia. 
 
Extract 2 
DR:  so we are on a spectrum of normal (0.2) memory and then with age 
     we forget so there’s some age related changes and then  
     eventually there is dementia. But in between that age related 
     change and dementia there’s a grey sort of area where (0.2) you  
     have what we call as mild (0.2) cognitive impairment.  
 
In the 9 meetings where a diagnosis was not named, explanations were given for 
patient symptoms.  
 
In 6 of these meetings symptoms were attributed to vascular disease. 
 




DR:  I think you have got some (0.4) you know (0.2) changes in memory 
     and language (0.4) because of age related change to the- to the 
     blood vessels in the brain 
 
Vascular disease was also presented as the primary explanation of symptoms in 
10/29 of the meetings where MCI was named and all the meetings where VCI was 
named (5/5).  
 
For 5 of the meetings where MCI was named and 3 where no diagnosis was named, 
symptoms were explained as a result of low mood or anxiety.   
 
Extract 4 
DR:  I think you’ve got (0.3) some cognitive impairment 
PT:  okay 
DR:  um so (.) pr- a problem with memory or thinking 
     (.) 
DR:  and I think (.) the (0.7) y- the cause of that- we- so we often  
     have this (0.4) what they call a diagnosis of mild cognitive  
     impairment  
     (0.6) 
DR:  the cause of that can be (.) lots of things. 
     (.) 
DR:  so age plays a part  
PT:  mm 
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     (0.3) 
DR:  um (.) certainly things like anxiety can [play a part] 
PT:                                           [mm         ] 
     (0.6) 
DR:  and sometimes some of that can be unconscious (.) you’re not  
     aware of it?  
     (0.8) 
DR:  um (1.4) you know it may well be that there’s (0.4) a degree of  
     unconscious anxiety about things about the future for [example] 
PT:                                                        [mhm    ] 
     (.) 
DR:  that’s play- having a- an effect on your attention on your  
     ability to concentrate and a- and attend to things and that then  
     has a knock on effect on memory 
 
In one case, the doctor attributed the patient’s MCI to alcoholism. 
 
The diagnoses and explanations were categorised for quantitative analysis. The first 
categorisation was whether MCI/VCI was named (n=34, 79%) or not (n=9, 21%). The 
second categorisation was the explanation for symptoms: (1) impairment caused by 
vascular conditions (n=21, 49%); (2) impairment as a stage between age and 
dementia (n=13, 30%); or (3) impairment caused by mood or alcoholism (n=9, 21%).  
 
Prognosis discussions 




Prognosis was discussed in all but one of the meetings. In the latter, the patient was 
highly anxious and the discussion focused on management of anxiety. 
 
In 23 meetings (54%) prognosis discussions included an explicit indication that 
dementia was a possibility.  
 
Extract 5 
DR:  some people (0.2) with mild cognitive impairment do (0.2) get  
     (0.4) worse (0.4) eventually and get a dementia  
 
In most of these cases dementia was discussed as a possibility in the future, but in 7 
cases the doctors indicated the possibility of the patient having dementia already. 
 
Extract 6 
DR:  you know we could be seeing the very early signs of something  
     like a (0.2) a vascular dementia  
 
In the remaining 46% (20/43) meetings doctors implied that the condition can 
progress but did not mention dementia. In 13 of these meetings (30% of total) 
doctors stated an expectation that the patient’s condition would not get worse.  
 




DR:  the brain’s a bit like that you know once a certain amount 
     of change has happened it can’t (0.2) get older [if you] know  
PT:                                                [mm    ]  
DR:  what I mean  
PT:  ye[ah] 
DR:    [th]e change [is  ] already there 
PT:               [yeah]  
PT:  yeah 
DR:  and so generally (0.4) you know (0.2) things should settle down  
     and stay (.) pretty much (0.4) at the level that they’re at now 
 
Prognosis was also coded as to whether dementia was mentioned as a possibility for 
the future (n=23, 53%) or not (n=20, 47%). This was not associated with whether a 
diagnosis was named (Fisher’s exact = .26) or the explanation given to the patient 
(Fisher’s exact = .15) (see Figure 1). 
 
In 38 prognosis discussions (88%) doctors spoke about lifestyle modifications that 




DR:  whatever is good for your heart is good for your brain 
CR:  yeah 
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     (0.3) 
DR:  so (0.3) m i- i- some mild moderate exercise (.) walking  
     gardening 
PT:  hm hm 
     (0.3) 
DR:  that's good (0.3) healthy diet (0.5) u:m (.) hydration 
 
Medication to prevent progression was discussed in 7 meetings (16%), specifically 
continuing/prescribing cardiovascular medications to prevent more vascular damage 
(4/7), reducing high doses of medication (2/7) and prescribing medication for anxiety 
(1/7). Eight patients (19%) were directed towards available research projects. 
 
Patient and companion understanding   
Patients and companions were asked to report their diagnosis (recorded 
immediately after the diagnosis meeting) to illustrate understanding. These showed 
some discrepancy with the diagnosis named (see Table 2).  
[INSERT TABLE 2 HERE] 
Seventeen of the 40 patients (43%) and 19/30 companions (63%) who answered the 
diagnosis question reported the same diagnosis or explanation of symptoms as the 
doctor. Of the patients who were told they had MCI, 10/29 (38%) and 12/27 
companions (44%) reported MCI. Of the patients who were told they had VCI, 3/5 
patients and 4/5 companions reported vascular problems as the diagnosis.  




Of the 9 patients who were given an explanation of symptoms without a specific 
diagnostic label, 2 patient-companion dyads reported the same cause (1 age-related, 
1 vascular).  
 
Both patients and companions were more likely to report MCI or VCI as the diagnosis 
when these diagnoses were named by the doctor (Fisher’s exact = .012 and .00 
respectively).  
 
There was a significant association between whether prognosis included dementia 
and patient and companion reported diagnoses (Fisher’s exact = 0.004 and 0.018). In 
all cases where patients reported MCI as their diagnosis (and in all but 1 where 




All the patients in this study had a diagnosis of MCI/VCI, but the communication of 
the diagnostic label, explanation of symptoms and likely prognosis varied. Doctors 
appeared to categorise patients into different subtypes of MCI in how they explained 
symptoms. This was not related to whether dementia was discussed as a possible 
prognosis. Nearly half of prognosis discussions did not refer to dementia and 30% 
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explicitly stated an expectation that MCI would not progress to dementia. Only 38% 
and 44% of patients and companions named their diagnosis as MCI after the 
meeting. This was more likely to occur when MCI was named to the patient and 
prognosis discussions included dementia. 
 
Variation in causal explanations reflecting doctor beliefs about MCI etiology 
There was a clear range in how doctors explained MCI symptoms: varying between 
explanations of MCI as a result of vascular damage, MCI as a stage between 
cognitive ageing and dementia, and MCI caused by mood or anxiety. In 
differentiating between the first two types doctors may be speaking to a distinction 
between non-vascular, pre-Alzheimer’s MCI and MCI (or VCI) due to vascular 
pathology, which is well defined elsewhere9. That the MCI/VCI label was not used in 
20% of the meetings may reflect a reluctance to use the diagnosis stemming from 
beliefs about its ambiguity. These views were discussed in focus groups with these 
clinicians as part of the ShareD project11 and reflect clinicians reports of diagnostic 
value13,25.  
  
It is noteworthy that 21% patients were given an MCI diagnosis attributed to mood, 
while 10% patients in wider dataset were given non-MCI diagnoses of depression or 
anxiety. There is a complex relationship between anxiety, depression, MCI and 
dementia, with some suggesting a continuum of symptoms and others identifying 
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mood disturbance as a risk factor for progression to dementia2,26-28.  The variation in 
prognostic communication may therefore reflect whether doctors identify 
depression or anxiety as (1) manifesting through memory problems (i.e. as a 
‘pseudodementia’) or (2) as a precursor to dementia. When giving an MCI diagnosis 
explained as a mood disorder, it may be that doctors are unclear as to which of 
these options the patient has. There is confusion around the relationship between 
these conditions, with evidence that people with MCI and co-morbid psychiatric 
conditions are more likely to revert to normal cognition than progress to dementia29, 
but depression also being classed as a dementia risk factor30. The doctors in this 
study more often discussed dementia as a possibility in MCI attributed to mood than 
with MCI attributable to vascular changes. While it may have been expected that the 
variation in prognosis discussions would depend on clinical judgement of the 
etiology for the patient’s MCI and the potential for reversibility, there was no 
association between the diagnosis labels or explanations presented to patients and 
whether dementia was discussed.  
Patient experience and understanding as a result of diagnostic communication 
In previous work patients and companions experience MCI diagnoses as confusing 
and frustrating31. The varying patient and companion reports on diagnosis 
demonstrate confusion around MCI that is present in other studies32. “No problem” 
and “not dementia” were frequently reported regardless of whether a label was 
used and the explanation given, which may reflect the fact that the doctors explicitly 
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told the patients they did not have dementia in all but one consultation. While this 
may later be contradicted (for example in Extract 6 where the doctors says the 
patient’s symptoms may be the start of vascular dementia), emphasising the 
absence of dementia at the beginning of diagnosis discussions may be distracting 
from other aspects of diagnostic information that doctors wish to convey.  
 
While doctors using the labels MCI or VCI naturally led to more people reporting 
MCI/VCI as their diagnosis, 62% of patients and 56% of companions who were told 
MCI did not report this immediately after the meeting. This may reflect studies 
demonstrating that people with MCI conceptualise their condition according to 
lifestyle rather than biological factors33. The low reporting of diagnosis labels may 
also reflect previously reported mistrust of MCI diagnoses, with many believing their 
symptoms are more severe than MCI suggests16.  MCI labels were reported more 
often when doctors included dementia in prognostic discussions, which suggests the 
diagnosis is better understood when it is framed as a “pre-dementia” state. 
 
Discussion of increased dementia risk at MCI diagnosis 
It has been argued that the primary reason to disclose an MCI diagnosis is to set 
appropriate expectations for the future1. However, dementia was not mentioned 
explicitly as a possibility in 46% of meetings and in 30% of meetings doctors 
expressed an expectation the patient’s condition would not progress. These findings, 
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while comparable to other studies13, conflict with MCI guidelines that recommend 
clinicians discuss future planning with patients at diagnosis34,35.  
 
Our previous work on dementia diagnosis found progression was only explicitly 
mentioned in 38% of meetings18. Doctors reported a need to balance hope with bad 
news of dementia, leading to an emphasis on medication and support over 
discussions of the future11. This is mirrored in MCI diagnosis, where 88% of the 
consultations contained discussions of modifiable lifestyle factors that may 
ameliorate symptoms, and 16% discussed medication having preventative effects. 
While evidence suggests there are modifiable risk factors for progression to 
dementia2,36-37, the emphasis on lifestyle changes and medication while downplaying 
progression may lead to unrealistic expectations. People with MCI have been shown 
to have lower affect than patients with early dementia, often stemming from anxiety 
for the future38, and therefore a balance of realistic and positive prognostic 
discussions is particularly important.  
 
Strengths and limitations: scope for future research 
The use of CA as a rigorous micro-analytic method of exploring MCI diagnosis 
delivery in practice is a strength of this study. The video recordings were collected 
from 12 doctors across three UK sites in two different geographical areas enhancing 
generalisability. A limitation is that it was not possible to verify the diagnoses 
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reported, future longitudinal research where accuracy of clinical diagnosis is 
ascertained will be beneficial in further exploring the issues raised in this study. The 
fact that 15 videos came from one doctor may skew our findings, and also reflects a 
potential bias according to doctor likelihood to diagnose MCI which was not 
captured in this study. Additionally, MCI is a heterogenous diagnosis with 
complicating factors in the choice of communication that we did not explore. For 
example, future research could examine the effect of doctor perspectives on 
subtype and prognosis. There are also other factors that may affect patient and 
companion understanding and reporting of their diagnosis: future research could 
explore whether clearer communication about future risk of dementia motivates 
behaviour change in relation to modifiable risk factors such as smoking, alcohol, 
hypertension and physical activity. 
 
Conclusion 
This conversation analysis of MCI diagnosis delivery has shown how varying clinician 
perspectives on the cause and prognosis of MCI may result in mixed signals to 
patients. While further research on the accuracy, progression, and patient 
understanding of MCI diagnoses in practice is needed to provide definitive guidance, 
preliminary recommendations can be suggested from these findings. The variation in 
diagnostic information communicated to patients is likely to be a reflection of the 
heterogeneity of MCI as considered by clinician assessment of each individual 
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patient, i.e. either as being in a pre-dementia stage of cognitive decline or a 
potentially reversible condition of cognitive impairment. It may be that a consensus 
definition of MCI would lead to more consistent communication thus increasing 
patient understanding. Clearer communication specifically about the risk of 
developing dementia is also necessary. Evidence suggests that lifestyle changes may 
reduce the risk of progression to dementia. Prognostic information would therefore 
be crucial to empower patients to implement such changes. Co-production of clinical 
guidelines or advice, guided by further research, would be beneficial. 
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   Female 
   Male 
 
Age 
  35-44 
  45-54 
  55-64 
 
Ethnicity 
   White British 
   Indian 
   Asian/Asian British 
 
Doctor Type 
   Psychiatrist 
   Geriatrician  
   Specialty doctor 
 
N=12 























   London 







   Female 





   White British 
   Indian 
   Bangladeshi 
 
Diagnosis 
  MCI 
  VCI 
 


















mean=83/100, SD=8.4, range 60-94 
29/30 












   Female 





   White British 
   Indian 
   Bangladeshi 
 
Relationship to Patient 
   Spouse/Partner 
   Child/Child-in-law 
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Table 2: Named and Reported Diagnoses 
Diagnosis named by 





MCI diagnosis (stage 
between ‘normal’ ageing 
and dementia, n=12)  
MCI n=4 
Age n=2 
‘Don’t know’ n=2 




‘No problem’ n=3 
Missing n=3 
VCI (vascular disease, n=5) Vascular disease n=3 
‘Not dementia’ n=2 
Vascular disease n=4 
Missing n=1 




Vascular disease n=2 
‘Don’t know’ n=1 
MCI n=6 
No companion n=2 
Missing n=2 
 




‘Don’t know’ n=1 
MCI n=2 
‘No problem’ n=2 
Missing n=1 
MCI (alcohol, n=1) Alcohol n=1 Alcohol n=1 
No diagnosis (vascular 
disease, n=6) 
Vascular disease n=2 
Age n=1 
No problem n=2 
Missing n=1 
Vascular disease n=1 
Age n=1 
No problem n=1 
No companion n=2 







No diagnosis (low mood or 
anxiety, n=3) 
Vascular changes n=1 
‘No problem’ n=1 
 Missing n=1 
Vascular disease n=1 
Age n=1 
No companion n=1 
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Figure 1: Flow of Diagnostic Information 
